Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.155
-0.015 (-0.69%)
May 8, 2025, 12:21 PM - Market open

Larimar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
138247200179191329
Upgrade
Market Cap Growth
-71.57%23.61%11.79%-6.49%-41.88%-
Upgrade
Enterprise Value
-164911060119233
Upgrade
Last Close Price
2.173.874.554.1310.7921.41
Upgrade
PB Ratio
0.961.442.441.612.973.67
Upgrade
P/TBV Ratio
0.951.442.441.612.973.67
Upgrade
Debt / Equity Ratio
0.030.030.070.050.090.07
Upgrade
Quick Ratio
7.177.589.1611.067.9510.31
Upgrade
Current Ratio
7.488.029.4911.288.1610.89
Upgrade
Return on Equity (ROE)
-50.77%-63.59%-38.36%-40.33%-65.72%-95.47%
Upgrade
Return on Assets (ROA)
-31.47%-38.36%-23.48%-22.26%-34.40%-48.69%
Upgrade
Return on Capital (ROIC)
-34.17%-43.00%-25.64%-24.45%-37.86%-55.96%
Upgrade
Earnings Yield
-69.66%-32.64%-18.50%-19.78%-26.50%-12.92%
Upgrade
FCF Yield
-63.97%-28.86%-16.83%-15.48%-22.21%-12.85%
Upgrade
Buyback Yield / Dilution
-37.88%-39.53%-70.42%-50.09%-44.44%-95.09%
Upgrade
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q